Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities.
作者信息
Carlson Alise, McGinley Marisa P
机构信息
Cleveland Clinic, Cleveland, OH, USA.
出版信息
Mult Scler. 2022 Apr;28(4):499-501. doi: 10.1177/13524585221081985. Epub 2022 Mar 16.
Abstract
摘要
相似文献
1
Healthcare utilization in multiple sclerosis: Impact of disease modifying therapies and comorbidities.多发性硬化症的医疗保健利用：疾病修正疗法和合并症的影响。
Mult Scler. 2022 Apr;28(4):499-501. doi: 10.1177/13524585221081985. Epub 2022 Mar 16.
2
Impact of comorbidity on hospitalizations in individuals newly diagnosed with multiple sclerosis: A longitudinal population-based study.新诊断多发性硬化症患者合并症对住院的影响：一项基于人群的纵向研究。
Mult Scler Relat Disord. 2020 May;40:101955. doi: 10.1016/j.msard.2020.101955. Epub 2020 Jan 22.
3
Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable.健康、健康促进和共病对多发性硬化病程的影响：解决可改变的因素。
Neurol Clin. 2024 Feb;42(1):229-253. doi: 10.1016/j.ncl.2023.06.007. Epub 2023 Jul 28.
4
School performance, psychiatric comorbidity, and healthcare utilization in pediatric multiple sclerosis: A nationwide population-based observational study.儿科多发性硬化症患者的学业表现、精神共病和医疗保健利用：一项全国范围内基于人群的观察性研究。
Mult Scler. 2021 Feb;27(2):259-267. doi: 10.1177/1352458520959673. Epub 2020 Sep 25.
5
Health care services and disease modifying therapies use in community-based multiple sclerosis patients: Evolution from 2013 to 2015 and demographic characteristics.社区多发性硬化症患者的医疗保健服务及疾病改善疗法的应用：2013年至2015年的演变及人口统计学特征
Presse Med. 2019 Jan;48(1 Pt 1):e1-e19. doi: 10.1016/j.lpm.2018.04.013. Epub 2018 Dec 7.
6
Comorbidities Are Associated with Altered Health Services Use in Multiple Sclerosis: A Prospective Cohort Study.合并症与多发性硬化症中健康服务使用的改变相关：一项前瞻性队列研究。
Neuroepidemiology. 2018;51(1-2):1-10. doi: 10.1159/000488799. Epub 2018 May 15.
7
Health care utilization before and after intensive care unit admission in multiple sclerosis.重症监护病房收治前后多发性硬化症患者的医疗服务利用情况
Mult Scler Relat Disord. 2015 Jul;4(4):296-303. doi: 10.1016/j.msard.2015.05.010. Epub 2015 May 30.
8
Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work loss costs for patients with multiple sclerosis.提高对疾病修饰疗法的依从性对多发性硬化症患者医疗资源利用以及直接医疗和间接工作损失成本的影响。
J Med Econ. 2015;18(9):711-20. doi: 10.3111/13696998.2015.1044276. Epub 2015 Jun 1.
9
Healthcare utilization and costs of multiple sclerosis patients in the Netherlands: a healthcare claims database study.荷兰多发性硬化症患者的医疗保健利用情况及费用：一项医疗保健索赔数据库研究。
J Comp Eff Res. 2018 May;7(5):453-462. doi: 10.2217/cer-2017-0077. Epub 2018 May 18.
10
Comorbidity in multiple sclerosis: implications for patient care.多发性硬化症的合并症：对患者护理的影响。
Nat Rev Neurol. 2017 Jun;13(6):375-382. doi: 10.1038/nrneurol.2017.33. Epub 2017 Mar 17.
引用本文的文献
1
Exploring Different Levels of Contact Frequency in Multiple Sclerosis Care.探索多发性硬化症护理中不同程度的接触频率。
Brain Behav. 2025 Jul;15(7):e70634. doi: 10.1002/brb3.70634.
2
Subgroup analyses and patterns of multiple sclerosis health service utilisation: A cluster analysis.多发性硬化症医疗服务利用的亚组分析及模式：一项聚类分析。
Mult Scler J Exp Transl Clin. 2024 Jun 20;10(2):20552173241260151. doi: 10.1177/20552173241260151. eCollection 2024 Apr-Jun.
本文引用的文献
1
Emergency medical care for multiple sclerosis: A five-year population study in the Campania Region (South Italy).多发性硬化症的急诊医疗：坎帕尼亚大区（意大利南部）的一项为期五年的人群研究。
Mult Scler. 2022 Apr;28(4):597-607. doi: 10.1177/13524585221074010.
2
Disease-modifying drugs for multiple sclerosis and subsequent health service use.多发性硬化症的疾病修正药物和后续的医疗服务利用。
Mult Scler. 2022 Apr;28(4):583-596. doi: 10.1177/13524585211063403. Epub 2021 Dec 24.
3
A literature review of cost-of-illness studies on the economic burden of multiple sclerosis.一篇关于多发性硬化症经济负担的疾病成本研究文献综述。
Mult Scler Relat Disord. 2020 Aug;43:102162. doi: 10.1016/j.msard.2020.102162. Epub 2020 May 12.
4
Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.多发性硬化症患者接受芬戈莫德、那他珠单抗、利妥昔单抗和注射治疗的感染风险。
JAMA Neurol. 2020 Feb 1;77(2):184-191. doi: 10.1001/jamaneurol.2019.3365.
5
Multidisciplinary data infrastructures in multiple sclerosis: Why they are needed and can be done!多发性硬化症的多学科数据基础设施：为什么需要它们以及如何实现！
Mult Scler. 2019 Apr;25(4):500-509. doi: 10.1177/1352458518807076. Epub 2018 Nov 1.
6
The Multiple Sclerosis Care Unit.多发性硬化症护理单元。
Mult Scler. 2019 Apr;25(5):627-636. doi: 10.1177/1352458518807082. Epub 2018 Oct 23.
7
Evaluation of an integrated multidisciplinary approach in multiple sclerosis care: A prospective, randomized, controlled study.多发性硬化症护理中综合多学科方法的评估：一项前瞻性、随机、对照研究。
Mult Scler J Exp Transl Clin. 2015 Sep 28;1:2055217315608864. doi: 10.1177/2055217315608864. eCollection 2015 Jan-Dec.
8
New insights into the burden and costs of multiple sclerosis in Europe.欧洲多发性硬化负担和成本的新见解。
Mult Scler. 2017 Jul;23(8):1123-1136. doi: 10.1177/1352458517694432. Epub 2017 Feb 1.
9
How much is the cost of multiple sclerosis--systematic literature review.多发性硬化症的花费是多少——系统文献综述
Przegl Epidemiol. 2013;67(1):75-9, 157-60.
10
The cost burden of multiple sclerosis in the United States: a systematic review of the literature.美国多发性硬化症的费用负担：文献系统评价。
J Med Econ. 2013;16(5):639-47. doi: 10.3111/13696998.2013.778268. Epub 2013 Mar 7.
Zotero 插件